Literature DB >> 6195008

Axonal transport of acetylcholinesterase in the diabetic mutant mouse.

M Vitadello, J Y Couraud, R Hässig, A Gorio, L Di Giamberardino.   

Abstract

During the development of diabetic neuropathy in the mouse C57BL/Ks (db/db), the axonal transport of AChE molecular forms was tested in the sciatic nerve, by measuring the accumulation of enzyme activity in front of a nerve transection. No alteration of the fast flow rate of G4 and A12 molecular forms was found until 220 days of age. On the other hand, a reduced flow rate of G1 and G2 molecular forms, probably conveyed by slow axoplasmic flow, was noticed in the late phase of diabetic neuropathy. This result is consistent with the view that axonal dwindling could be related to disturbances of slow axonal transport and that the reduction in conduction velocity, observed at an earlier stage, may be due to other causes.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6195008     DOI: 10.1016/0014-4886(83)90249-2

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  6 in total

1.  Age-dependent slowing of enteric axonal transport in insulin-resistant mice.

Authors:  Kathy J LePard; Joseph Cellini
Journal:  World J Gastroenterol       Date:  2013-01-28       Impact factor: 5.742

2.  Impaired axonal transport of acetylcholinesterase in the sciatic nerve of alloxan-diabetic rats: effect of ganglioside treatment.

Authors:  P Marini; M Vitadello; R Bianchi; C Triban; A Gorio
Journal:  Diabetologia       Date:  1986-04       Impact factor: 10.122

3.  Diabetic neuropathy in db/db mice develops independently of changes in ATPase and aldose reductase. A biochemical and immunohistochemical study.

Authors:  R Bianchi; C Marelli; P Marini; M Fabris; C Triban; M G Fiori
Journal:  Diabetologia       Date:  1990-03       Impact factor: 10.122

4.  Experimental diabetic neuropathy: impairment of slow transport with changes in axon cross-sectional area.

Authors:  R Medori; L Autilio-Gambetti; S Monaco; P Gambetti
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

Review 5.  Criteria for creating and assessing mouse models of diabetic neuropathy.

Authors:  Kelli A Sullivan; Stephen I Lentz; John L Roberts; Eva L Feldman
Journal:  Curr Drug Targets       Date:  2008-01       Impact factor: 3.465

6.  Decreased glycolytic and tricarboxylic acid cycle intermediates coincide with peripheral nervous system oxidative stress in a murine model of type 2 diabetes.

Authors:  Lucy M Hinder; Anuradha Vivekanandan-Giri; Lisa L McLean; Subramaniam Pennathur; Eva L Feldman
Journal:  J Endocrinol       Date:  2013-01-02       Impact factor: 4.286

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.